References
- Guidelines for the management of snakebites, 2nd edition 2016 [Internet]. WHO; 2016 [cited 2024 Jan 29]. Available from: https://www.who.int/publications/i/item/9789290225300.
- Guidelines for the prevention and clinical management of snakebite in Africa 2010 [Internet]. WHO; 2010 [cited 2024 Jan 29]. Available from: https://www.who.int/publications/i/item/9789290231684.
- Slagboom J, Kool J, Harrison RA, Casewell NR. Haemotoxic snake venoms: their functional activity, impact on snakebite victims and pharmaceutical promise. Br J Haematol. 2017; 177:947–59.
- Harris J, Scott-Davey T. Secreted phospholipases A2 of snake venoms: effects on the peripheral neuromuscular system with comments on the role of phospholipases A2 in disorders of the CNS and their uses in industry. Toxins. 2013; 5:2533–71.
- Wittcoff H. The phosphatides. New York: Reinhold Publishing Corporation; 1951, p. 284.
- Murakami M, Kudo I. Phospholipase A2. J Biochem. 2002; 131:285–92.
- Nanjaraj AN, Yariswamy M, Vikram J, Nataraju A, Gowda TV, Vishwanath BS. Implications of phytochemicals in snakebite management: present status and future prospective. Toxin Rev. 2014; 33:60–83.
- Burke JE, Dennis EA. Phospholipase A2 structure/function, mechanism, and signaling. J Lipid Res. 2009; 50:237–42.
- Chen L, Liu C, Chang C. Isolation and characterization of a toxic phospholipase A2 from the venom of the Taiwan Habu (Trimeresurus mucrosquamatus). Biotechnol Appl Biochem. 1994; 19:61–73.
- Sandesha VD, Darshan B, Tejas C, Girish KS, Kempaiah K. A comparative cross-reactivity and paraspecific neutralization study on Hypnale hypnale, Echis carinatus, and Daboia russelii monovalent and therapeutic polyvalent anti-venoms. PLoS Negl Trop Dis. 2022; 16:e0010292. doi: 10.1371/journal.pntd.0010292
- Lizano S, Domont G, Perales J. Natural phospholipase A2 myotoxin inhibitor proteins from snakes, mammals and plants. Toxicon. 2003; 42:963–77.
- Marcussi S, Sant’Ana CD, Oliveira CZ, Rueda AQ, Menaldo DL, Beleboni RO, et al. Snake venom phospholipase A2 inhibitors: medicinal chemistry and therapeutic potential. Curr Top Med Chem. 2007; 7:743–56.
- Nishida M, Okamoto M, Ohno A, Okumura K, Hayashi K, Ikeda K, et al. Inhibitory activities of the heterotrimers formed from two α-type phospholipase A2 inhibitory proteins with different enzyme affinities and importance of the intersubunit electrostatic interaction in trimer formation. Biochim Biophys Acta. 2010; 1804:2121–7.
- Xiong S, Luo Y, Zhong L, Xiao H, Pan H, Liao K, et al. Investigation of the inhibitory potential of phospholipase A2 inhibitor gamma from Sinonatrix annularis to snake envenomation. Toxicon. 2017; 137:83–91.
- Le Z, Li X, Yuan P, Liu P, Huang C. Orthogonal optimization of prokaryotic expression of a natural snake venom phospholipase A2 inhibitor from Sinonatrix annularis. Toxicon. 2015; 108:264–71.
- Warrell DA. Snake venoms in science and clinical medicine 1. Russell’s viper: biology, venom and treatment of bites. Trans R Soc Trop Med Hyg. 1989; 83:732–40.
- Holzer M, Mackessy SP. An aqueous endpoint assay of snake venom phospholipase A2. Toxicon. 1996; 34:1149–55.
- Kondo H, Kondo S, Ikezawa H, Murata R, Ohsaka A. Studies on the quantitative method for determination of hemorrhagic activity of Habu snake venom. Jpn J Med Sci Biol. 1960; 13:43–51.
- Estevão-Costa MI, Rocha BC, de Alvarenga Mudado M, Redondo R, Franco GR, Fortes-Dias CL. Prospection, structural analysis and phylogenetic relationships of endogenous ϒ-phospholipase A2 inhibitors in Brazilian Bothrops snakes (Viperidae, Crotalinae). Toxicon. 2008; 52:122–9.
- Faisal T, Tan KY, Sim SM, Quraishi N, Tan NH, Tan CH. Proteomics, functional characterization and antivenom neutralization of the venom of Pakistani Russell’s viper (Daboia russelii) from the wild. J Proteomics. 2018; 183:1–13.
- Lingam TMC, Tan KY, Tan CH. Proteomics and antivenom immune profiling of Russell’s viper (Daboia siamensis) venoms from Thailand and Indonesia. J Venom Anim Toxins Incl Trop Dis. 2020; 26:e20190048. doi: 10.1590/1678-9199-jvatitd-2019-0048
- Georgieva D, Arni RK, Betzel C. Proteome analysis of snake venom toxins: pharmacological insights. Expert Rev Proteomics. 2008; 5:787–97.
- Tsai I, Wang Y, Chen Y. Variations of phospholipases A2in the geographic venom samples of Pitvipers. J Toxicol Toxin Rev. 2003; 22:651–62.
- Liu CC, You CH, Wang PJ, Yu JS, Huang GJ, Liu CH, et al. Analysis of the efficacy of Taiwanese freeze-dried neurotoxic antivenom against Naja kaouthia, Naja siamensis, and Ophiophagus hannah through proteomics and animal model approaches. PLoS Negl Trop Dis. 2017; 11:e0006138. doi: 10.1371/journal.pntd.0006138
- Quirós S, Alape-Girón A, Angulo Y, Lomonte B. Isolation, characterization and molecular cloning of AnMIP, a new α-type phospholipase A2 myotoxin inhibitor from the plasma of the snake Atropoides nummifer (Viperidae: Crotalinae). Comp Biochem Physiol B Biochem Mol Biol. 2006; 146:60–8.